Understanding ED: Why It's Often a Circulatory Warning Before It's a Sex Problem

Most men who develop erectile dysfunction want one thing: for it to stop. Understandable. But treating ED as purely a bedroom problem means missing what it frequently is — one of the earliest visible signals of vascular disease, arriving on average three to five years before a cardiac event.

That's not a scare tactic. It's an anatomical consequence, and once you see the mechanism it's obvious.

The plumbing argument

An erection is a hydraulic event that depends on healthy blood vessels and functioning nerves. Sexual stimulation triggers nerve endings and endothelial cells in the penis to release nitric oxide. Nitric oxide activates an enzyme that produces cyclic GMP. Cyclic GMP relaxes the smooth muscle lining the arteries of the corpora cavernosa. Those arteries dilate, blood floods in faster than it can drain, the expanding tissue compresses the outflow veins, and pressure holds.

Every step depends on endothelial function — the health of the single-cell lining of your blood vessels. The endothelium is where atherosclerosis begins, long before any plaque is visible on a scan. Endothelial dysfunction — a reduced capacity to produce nitric oxide and dilate on demand — is the earliest measurable stage of vascular disease.

Now the size comparison that makes this click:

The same disease process, developing at the same rate throughout your arterial tree, produces a functional problem in the smallest vessels first. A degree of narrowing and endothelial impairment that causes no symptoms at all in a coronary artery is enough to make a 1 mm penile artery fail to deliver.

This is why ED so often precedes angina, heart attack, and stroke. It isn't a separate condition that happens to correlate. It's frequently the same condition, detected earlier, because the anatomy made it visible sooner.

Which reframes the whole thing. New-onset ED without an obvious cause isn't only a reason to get a prescription. It's a reason to get a cardiovascular workup.

What actually causes it

ED is a symptom with several possible drivers, and they often coexist.

Vascular (the most common). Endothelial dysfunction and atherosclerosis, driven by the familiar list: elevated ApoB and LDL, hypertension, insulin resistance and diabetes, smoking, visceral adiposity, sedentary living.

Metabolic. Insulin resistance impairs nitric oxide signaling directly, independent of plaque. This is one reason ED can appear in men in their thirties with normal-looking cholesterol but rising fasting insulin — and one reason fasting insulin belongs on your panel.

Neurological. Diabetic neuropathy, spinal cord injury, multiple sclerosis, Parkinson's disease, pelvic surgery — prostatectomy in particular.

Hormonal. Low testosterone more reliably reduces libido than it causes ED outright, though it contributes. Thyroid disease and elevated prolactin also belong on the checklist. Hormones are part of the picture, rarely the whole picture.

Medication-induced — and commonly missed. SSRIs and SNRIs, thiazide diuretics, beta blockers, certain antipsychotics, some antihistamines, opioids, and finasteride in a minority of users. If ED began within weeks of starting a new medication, that is a lead worth pursuing before anything else.

Sleep apnea. Strongly associated and badly underdiagnosed. Nocturnal oxygen desaturation impairs endothelial function and suppresses testosterone. Treating apnea sometimes resolves ED with no other intervention.

Psychological. Performance anxiety, depression, relationship strain, and stress are real causes with real mechanisms — sympathetic nervous system activation directly opposes the parasympathetic signaling an erection requires. Anxiety about the problem then worsens the problem, which is the loop most men find themselves in.

A useful clinical distinction: if you reliably wake with erections and can achieve them alone but not with a partner, the cause is more likely psychological. If they've faded everywhere, gradually, over months to years, that pattern points vascular. Not diagnostic, but it's the question a good clinician asks first.

What a proper evaluation includes

If a service hands you a prescription after three questions and a credit card, you have received a transaction, not care. A real evaluation covers:

History. Onset — sudden or gradual. Nocturnal and morning erections present or absent. Situational or universal. Libido level. Complete medication list. Cardiovascular symptoms including exertional chest discomfort or breathlessness. Snoring and daytime sleepiness. Mood. Relationship context.

Vital signs. Blood pressure, and body composition beyond a BMI number.

Labs. At minimum:

• Total and free testosterone, drawn in the morning (levels follow a diurnal rhythm; an afternoon draw is uninterpretable) and confirmed on a second occasion before any treatment decision
• Fasting glucose and HbA1c, ideally with fasting insulin
• A lipid panel, with ApoB where available
• TSH and, if libido is markedly low, prolactin
• CBC and comprehensive metabolic panel as a baseline

Cardiovascular risk assessment. Given what ED predicts, this is the step most commonly skipped and the one most likely to matter for your life expectancy. Under the 2026 ACC/AHA dyslipidemia guideline, that means calculating risk with the PREVENT equations and measuring Lp(a) at least once in adulthood — relevant here because a man in his forties presenting with ED is exactly the patient in whom inherited risk should be identified.

Treatments, from first line down

PDE5 inhibitors

Sildenafil, tadalafil, vardenafil, avanafil. These remain first-line for good reason.

How they work. They don't create an erection. They block phosphodiesterase type 5, the enzyme that breaks down cyclic GMP. With less breakdown, the cGMP your body produces in response to sexual stimulation persists longer and its effect is amplified. Sexual stimulation is still required — this trips up plenty of first-time users who expect an automatic result.

How they differ:

The 36-hour window is why tadalafil is often preferred — it decouples the medication from the moment, which reduces the scheduling pressure that feeds performance anxiety. Low-dose daily tadalafil goes further: continuous coverage, no planning at all, and it also treats benign prostatic hyperplasia symptoms, which is a genuine two-for-one in men over 50.

Effectiveness. Roughly 60–70% of men respond well. Non-response is often fixable — inadequate dose, taken with a heavy meal, insufficient stimulation, or fewer than the 6–8 attempts it can take to find the right conditions. Genuine non-response after proper trials warrants further workup, because it points to more significant vascular or neurological disease.

The absolute contraindication, which is not negotiable. Never combine a PDE5 inhibitor with any nitrate. Nitroglycerin in any form — tablets, spray, patches, paste — plus isosorbide mononitrate or dinitrate. The combination can cause catastrophic, unresponsive hypotension. This includes emergency nitroglycerin given for chest pain, which is why every emergency clinician asks. It also includes recreational "poppers" (amyl nitrite). If you take any nitrate, PDE5 inhibitors are off the table entirely.

Other cautions. Caution with alpha blockers used for prostate symptoms (additive blood pressure drops — separate the timing and start low). Seek immediate emergency care for an erection lasting more than four hours; priapism can cause permanent tissue damage. Sudden vision or hearing loss is rare but requires stopping the drug and immediate evaluation. Discuss with a clinician if you have significant cardiovascular disease, recent stroke or heart attack, uncontrolled blood pressure, or advanced liver or kidney disease.

On buying these online. Sildenafil and tadalafil are among the most counterfeited medications in the world. Analyses of products from unlicensed online sellers have found wrong doses, wrong active ingredients, and contaminants including printer ink and amphetamines. These are inexpensive generics from licensed US pharmacies — there is no financial reason to take the risk.

The things that work and don't come in a bottle

Exercise has randomized trial evidence for ED. Aerobic training improves erectile function in men with vascular ED, with effect sizes that are clinically meaningful. The mechanism is direct: exercise improves endothelial nitric oxide production. It's the same pathway PDE5 inhibitors amplify — exercise improves the supply side.

Weight loss, particularly visceral fat. Visceral adipose tissue drives inflammation and impairs endothelial function, and it increases aromatase activity, converting testosterone to estradiol. Losing it improves both vascular function and hormonal balance. In men with obesity-related ED, meaningful weight loss produces meaningful improvement.

Treating sleep apnea. If you snore heavily, wake unrefreshed, or your partner has noticed you stop breathing, get tested. Effective treatment improves endothelial function and testosterone.

Reviewing medications. If an SSRI is the cause, alternatives exist — this is a conversation with your prescriber, not a reason to stop a medication that's helping your mental health.

Smoking cessation and moderating alcohol. Both are directly vasculotoxic.

When first-line isn't enough

Vacuum erection devices. Mechanical, effective, no drug interactions, covered by many insurers. Unromantic, which limits uptake, but they work — including in men who don't respond to PDE5 inhibitors.

Intracavernosal injections. Alprostadil, or combination formulations, injected into the corpora with a very fine needle. Success rates are high — often 80%+ — including in men who fail oral therapy. The idea is off-putting until the first attempt; discomfort is generally minimal. Requires in-office teaching.

Intraurethral suppositories. Less effective than injection, less invasive.

Penile implants. Surgical, and the option with the highest satisfaction rates in appropriately selected men who have exhausted other approaches. Reserved for that situation because it's irreversible.

Low-intensity shockwave therapy. Frequently marketed, and the evidence is genuinely mixed. Some randomized trials show benefit in men with mild vascular ED; others show no advantage over sham. Protocols, devices, and treatment counts vary widely between studies and between clinics, which makes results hard to compare. It's plausible and unsettled — worth knowing that if a clinic presents it as established, the literature doesn't support that confidence.

Where testosterone fits

Testosterone therapy is not an ED treatment in men with normal testosterone. In men with genuinely low levels — confirmed on two morning draws alongside consistent symptoms — treatment often improves libido substantially and may improve erectile function modestly, sometimes by improving response to PDE5 inhibitors rather than working alone.

Two things worth knowing before starting. Testosterone therapy suppresses your own production and impairs fertility, sometimes persistently; if you may want children, raise this before your first dose, because there are alternative approaches. And it requires ongoing monitoring — hematocrit, PSA where age-appropriate, estradiol, and symptoms. It's a long-term medical relationship, not a subscription.

The reframe worth taking away

Erectile dysfunction is a symptom. Sometimes the symptom is anxiety. Sometimes it's a medication. And often it's the earliest visible evidence that your vascular system is under strain — showing up in the smallest arteries first, giving you a several-year head start on a problem that will eventually reach the ones you can't live without.

Treated as a plumbing inconvenience, you fix tonight. Treated as information, you may fix the next twenty years.

Your reserve — arterial health, metabolic flexibility, cardiorespiratory capacity — is built in the decades before you need it. This is one of the few times your body tells you the balance is dropping while there's still time to do something about it.

The right next step is a real evaluation. Labs, medication review, cardiovascular risk assessment, and then treatment. In that order.

---

Frequently asked questions

Does ED mean I'm going to have a heart attack? No — but it meaningfully raises the probability that vascular disease is present, and it typically precedes cardiac events by three to five years. That's an argument for evaluation, not alarm. Found early, most of the underlying risk is modifiable.

Sildenafil or tadalafil? Tadalafil's long duration and daily low-dose option suit most people better, and it helps prostate symptoms too. Sildenafil is shorter-acting and some men simply respond better to it. Either is a reasonable start; individual response varies more than the drugs do.

Is ED normal with age? More common with age, yes. "Normal" implies nothing can be done, which is false. Age-associated ED is largely vascular, and vascular health is modifiable at any age.

It happened once. Should I worry? No. Occasional difficulty is universal and usually reflects alcohol, fatigue, stress, or illness. Worry is itself a cause — the anxiety loop is real. A persistent pattern over weeks to months is what warrants evaluation.

Can I get treated without a physical exam? Telehealth evaluation with a licensed clinician is appropriate for many men, provided it includes a thorough history, a medication review, and labs. An in-person exam is warranted in specific situations, and a good clinician will tell you when.